TERPS Trial for de Novo Oligometastic Prostate Cancer
Public ClinicalTrials.gov record NCT05223803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Randomized Total Eradication of Metastatic Lesions Following Definitive Radiation to the Prostate in de Novo oligometaStatic Prostate Cancer (TERPS) Trial
Study identification
- NCT ID
- NCT05223803
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Interventions
- Prostate radiation (XRT) Radiation
- Stereotactic ablative radiation therapy (SABR) Radiation
- Systemic Therapy Drug
Radiation · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 17, 2022
- Primary completion
- Jul 30, 2026
- Completion
- Jul 30, 2027
- Last update posted
- Nov 9, 2025
2022 – 2027
United States locations
- U.S. sites
- 9
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC San Diego Moores Cancer Center | La Jolla | California | 92093 | Recruiting |
| Maryland Proton Treatment Center | Baltimore | Maryland | 21201 | Recruiting |
| UMMC | Baltimore | Maryland | 21201 | Recruiting |
| Upper Chesapeake Health | Bel Air | Maryland | 21014 | Not yet recruiting |
| Central Maryland Radiation Oncology | Columbia | Maryland | 21044 | Recruiting |
| Baltimore Washington Medical Center | Glen Burnie | Maryland | 21061 | Recruiting |
| Sidney Kimmel Cancer Center at Jefferson Health | Philadelphia | Pennsylvania | 19107 | Recruiting |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | Recruiting |
| Bon Secours Cancer Institute at St. Francis | Midlothian | Virginia | 23114 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05223803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05223803 live on ClinicalTrials.gov.